Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Thoracic 1Lymphoid 1Head & Neck 1Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Head and Neck Neoplasms 276Squamous Cell Carcinoma of Head and Neck 241Carcinoma, Non-Small-Cell Lung 86Melanoma 68Neoplasms 61Colorectal Neoplasms 52Neoplasm Metastasis 48Carcinoma, Squamous Cell 48Thyroid Neoplasms 47Breast Neoplasms 41Carcinoma, Renal Cell 36Lung Neoplasms 34Ovarian Neoplasms 33Oropharyngeal Neoplasms 30Stomach Neoplasms 29Mouth Neoplasms 29Nasopharyngeal Carcinoma 28Triple Negative Breast Neoplasms 26Uterine Cervical Neoplasms 25Sarcoma 25Laryngeal Neoplasms 24Pancreatic Neoplasms 23Esophageal Neoplasms 23Salivary Gland Neoplasms 21Urinary Bladder Neoplasms 20Recurrence 19Nasopharyngeal Neoplasms 18Small Cell Lung Carcinoma 17Carcinoma, Transitional Cell 17Prostatic Neoplasms 16

Interventions

PLX8394 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Histiocytosis × Head & Neck × Clear all
NCT02012231 2020-10-19

Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.

Fore Biotherapeutics

Phase 1 Terminated
5 enrolled
DermatologicEndocrineGastrointestinalHead & NeckMyeloidOther hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Leukemia, Hairy Cell, Melanoma, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis, Cholangiocarcinoma, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡